Hypersomnia’s and Neurologic Sleep Disorders

These practice parameters pertain to the treatment of hypersomnia’s of central origin. It serves as both an update of previous practice parameters for the therapy of narcolepsy and as the first practice parameters to address treatment of other hypersomnia of central origin. Specific disorders addressed by these parameters are narcolepsy (with or without cataplexy, due to medical condition), the idiopathic hypersomnia, recurrent hypersomnia and hyperxsomnia due to medical condition. Central hypersomnias are diseases manifested in excessive daytime sleepiness (EDS) not caused by disturbed nocturnal sleep or misaligned circadian rhythms. The Central hypersomnias includes narcolepsy with or without cataplexy, idiopathic hypersomnia. recurrent hypersomnia, with and without long sleep , behaviorally induced insufficient sleep disorder, Narcolepsy and hypersomnia due to medical conditions, and finally hypersomnia induced by substance intake. Epworth Sleepiness Scale is a subjective tool mostly used for Excessive daytime sleepiness assessment, Whereas the Multiple Sleep Latency Test serves as an objective diagnostic method for narcolepsy and idiopathic hypersomnias. As for symptomatic therapy of EDS, the central nervous system stimulants modafinil and methylphenidate seem to work well in most cases and in narcolepsy and Parkinson’s disease; sodium oxybate also has notable therapeutic value. In 1966, William Dement proposed that patients with excessive daytime sleepiness, but without cataplexy, sleep paralysis, or sleep-onset rapid eye movement (REM), should not be considered narcoleptic. In 1972, Roth described a type of hypersomnia with sleep drunkenness that consists of difficulty coming to complete wakefulness, confusion, disorientation, poor motor coordination, and slowness, accompanied by deep and prolonged sleep. The abrupt sleep attacks seen in classic narcolepsy are not present in this disorder.

  • Primary hypersomnias : origin and causes
  • Primary hypersomnia mimics and genetic roots
  • Secondary hypersomnias as underlying symptoms of other disorders

Related Conference of Hypersomnia’s and Neurologic Sleep Disorders

November 16-17, 2018

4th World Congress on Epilepsy and Treatment

| Radisson Narita | Tokyo, Japan
November 16-17, 2018

18th Global Neuroscience Conference

| Radisson Narita | Tokyo, Japan
November 19-20, 2018

8th International Congress on Stroke and Neurology

Holiday Inn – Marne La Vallée Paris, France
November 22-23, 2018

World Congress on Epilepsy and Brain Disorders

Cape Town, South Africa
November 26-27, 2018

World Neuron Congress

Helsinki, Finland
December 5-7, 2018

World Brain Congress

Dubai, UAE
December 13-15, 2018

13th Annual Conference on Dementia and Alzheimers Disease

Abu Dhabi, UAE
January 28-29, 2019

World Congress on Advances in Neurology and Neuromuscular Diseases

| Holiday Inn Atrium | Singapore
January 30-31, 2019

4th World Congress on Sleep Disorders, Medicine and Neuropsychiatry

Radisson Hotel Narita, Tokyo, Japan
February 15-16, 2019

11th International Conference on Vascular Dementia

Amsterdam | Netherlands
Feb 25-26, 2019

World Congress on Down Syndrome, Autism & Cerebral Palsy

Radisson Hotel Narita, Tokyo, Japan
February 25-26, 2019

6th World Congress on Spine and Spinal Disorders

| Radisson Hotel Narita | Tokyo,Japan
February 27-28, 2019

5th International Conference on Neuro-Oncology and Brain Tumor

Courtyard Marriott Seoul Times Square | Seoul,South Korea
February 28 – March 01, 2019

28th World Congress on Neurology and Therapeutics

Berlin, Germany
March 18-19, 2019

World Depression Congress

Dubai, UAE
March 20-21, 2019

11th World Congress on Alzheimers Disease & Dementia

Sydney, Australia
March 25-26, 2019

8th International Conference on Psychoneuroimmunology

Bucharest, Romania
March 25-26, 2019

31st World Congress on Neurology & Neuroscience

Osaka, Japan
April 11-12, 2019

International Conference on Neurology & Mental Disorders

Stockholm, Sweden
April 22-23, 2019

26th World Congress on Neurology and Neurodisorders

| Radisson Hotel Narita, Tokyo, Japan
May 08-09, 2019

5th Global Experts Meeting on Parkinsons, Huntingtons & Movement Disorders

Radisson Hotel Narita, Tokyo, Japan
May 15-16, 2019

13th Global Neurologists Meeting on Neurology and Neurosurgery

Mercure Albert Park, Melbourne, Australia
May 15-16, 2019

14th World Congress on Advances in Alzheimers and Dementia

Mercure Albert Park, Melbourne, Australia
May 22-23, 2019

13th World Congress on Advances and Innovations in Dementia

| Radisson Narita | Tokyo, Japan
May 23-24, 2019

28th World Congress on Neurology & Neuroscience

Zurich, Switzerland
June 17-18, 2019

9th International Conference on Addictive Disorders and Alcoholism

Novotel Brisbane, Australia
June 21-22, 2019

American Neuroscience and Neurosurgery Congress

Ottawa, Canada
July 22-23, 2019

9th Global Experts Meeting on Advances in Neurology and Neuropsychiatry

Mercure Albert Park, Melbourne, Australia
July 22-24, 2019

32nd European Neurology Congress

London, UK
August 12-13, 2019

4th World Congress on Pediatric Neurology and Pediatric Surgery

Auckland, New Zealand
August 29-30, 2019

5th International Conference on Epilepsy & Treatment

Vienna, Austria
August 29-30, 2019

5th International Conference on Epilepsy & Treatment

Vienna, Austria
August 29-31, 2019

5th World Congress on Parkinsons & Huntington Disease

Vienna, Austria
September 11-12, 2019

31st International Conference on Mental and Behavioral Health

| Holiday Inn Atrium | Singapore
September 11-12, 2019

6th International Conference on Dual Diagnosis Disorders

| Holiday Inn Atrium | Singapore
October 21-22, 2019

World Congress on Advances in Brain Injury, Disorders and Therapeutics

| Radisson Hotel Narita, Tokyo, Japan
November 19-20, 2019

32nd Clinical Neuroscience and Neurogenetics Conference

Istanbul, Turkey

Hypersomnia’s and Neurologic Sleep Disorders Conference Speakers

Recommended Sessions

Related Journals

Are you interested in